Startseite Racial and ethnic representation in 17-hydroxyprogesterone caproate preterm birth prevention studies: a systematic review
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Racial and ethnic representation in 17-hydroxyprogesterone caproate preterm birth prevention studies: a systematic review

  • Megan M. Smith , Jeremy M. Weber , Tracy Truong , Geeta K. Swamy und Sarahn M. Wheeler EMAIL logo
Veröffentlicht/Copyright: 29. August 2022

Abstract

Objectives

The US preterm birth rate varies dramatically by race and ethnicity yet the racial and ethnic representation within studies evaluating 17-hydroxprogesterone caproate (17-P) for preterm birth prevention is unknown. The objectives of our study were to 1) examine the racial and ethnic representation of participants in 17-P preterm birth prevention studies, 2) evaluate adherence to the NIH race and ethnicity reporting guidelines and 3) compare racial and ethnic representation in research studies to national preterm birth incidence.

Methods

We systematically reviewed US studies published between January 2000 and December 2019. Study participant’s race and ethnicity were reported using descriptive statistics then compared to US 2017//2018 preterm birth data using Pearson’s chi-square.

Results

Eighteen studies met the inclusion criteria, 17 studies reported race, 11 studies reported ethnicity, and yet none of the studies followed the NIH criteria. Compared to 2017/2018 US preterm births, the proportion of black/African American study participants was significantly higher whereas the proportions of all other race categories were lower.

Conclusions

More detailed reporting of race and ethnicity is needed in 17-P literature. Black women appear to be well represented while other racial and ethnic groups may be understudied.


Corresponding author: Sarahn M. Wheeler, MD, Department of Obstetrics and Gynecology, Duke University Medical Center, 2608 Erwin Road Suite #210, Durham, NC 27710, USA, Phone: 919 684 8111, Fax: 919 681 7861, E-mail:
Meeting Presentation Disclosure: This data was presented in part as a poster presentation at the 2019 North Carolina Ob/Gyn Society Annual Meeting April 5–9, 2019 in Raleigh, NC.

Funding source: The National Center for Advancing Translational Sciences of the National Institutes of Health

Award Identifier / Grant number: 1KL2TR002554

Funding source: National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research

Award Identifier / Grant number: UL1TR002553

Acknowledgments

The Duke BERD Method Core’s support of this project was made possible (in part) by Grant Number UL1TR002553 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCATS or NIH.

  1. Research funding: Dr. Wheeler is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number 1KL2TR002554. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt (Pro00100909) prior to initiation.

References

1. Goldenberg, R, Culhane, J, Iams, J, Romero, R. Preterm birth 1: epidemiology and causes of preterm birth. Obstet Anesth Digest 2009;29:6–7. https://doi.org/10.1097/01.aoa.0000344666.82463.8d.Suche in Google Scholar

2. Blackwell, SC, Gyamfi-Bannerman, C, Biggio, JRJr., Chauhan, SP, Hughes, BL, Louis, JM, et al.. 17-OHPC to prevent recurrent preterm birth in singleton gestations (PROLONG study): a multicenter, international, randomized double-blind trial. Am J Perinatol 2019;37:127–36. https://doi.org/10.1055/s-0039-3400227.Suche in Google Scholar PubMed

3. 2018 premature birth report card. March of Dimes; 2018. Available from: www.marchofdimes.org/reportcard.Suche in Google Scholar

4. Kistka, ZA-F, Palomar, L, Lee, KA, Boslaugh, SE, Wangler, MF, Cole, FS, et al.. Racial disparity in the frequency of recurrence of preterm birth. Am J Obstet Gynecol 2007;196:131.e1–6. https://doi.org/10.1016/j.ajog.2006.06.093.Suche in Google Scholar PubMed

5. Manuck, TA. Racial and ethnic differences in preterm birth: a complex, multifactorial problem. Semin Perinatol 2017;41:511–8. https://doi.org/10.1053/j.semperi.2017.08.010.Suche in Google Scholar PubMed PubMed Central

6. Chambers, BD, Baer, RJ, McLemore, MR, Jelliffe-Pawlowski, LL. Using index of concentration at the extremes as indicators of structural racism to evaluate the association with preterm birth and infant mortality-California, 2011–2012. J Urban Health 2019;96:159–70. https://doi.org/10.1007/s11524-018-0272-4.Suche in Google Scholar PubMed PubMed Central

7. Wallace, ME, Green, C, Richardson, L, Theall, K, Crear-Perry, J. “Look at the whole me”: a mixed-methods examination of black infant mortality in the US through women’s lived experiences and community context. Int J Environ Res Publ Health 2017;14:727. https://doi.org/10.3390/ijerph14070727.Suche in Google Scholar PubMed PubMed Central

8. Committee on Practice Bulletins—Obstetrics, The American College of Obstetricians and Gynecologists. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 2012;120:964–73. https://doi.org/10.1097/AOG.0b013e3182723b1b.Suche in Google Scholar PubMed

9. Meis, PJ, Klebanoff, M, Thom, E, Dombrowski, MP, Sibai, B, Moawad, AH, et al.. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379–85. https://doi.org/10.1056/nejmoa035140.Suche in Google Scholar

10. Moher, D, Shamseer, L, Clarke, M, Ghersi, D, Liberati, A, Petticrew, M, et al.. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1. https://doi.org/10.1186/2046-4053-4-1.Suche in Google Scholar PubMed PubMed Central

11. Higgins, JPT, Altman, DG, Sterne, JAC, editors. Chapter 8: assessing risk of bias in included studies. In: Higgins, JPT, Churchill, R, Chandler, J, Cumpston, MS, editors. Cochrane handbook for systematic reviews of interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from: www.training.cochrane.org/handbook.Suche in Google Scholar

12. Health NIo. NOT-OD-15-089: racial and ethnic categories and definitions for NIH diversity programs and for other reporting purposes; 2015. Available from: https://grants.nih.gov/grants/guide/notice-files/not-od-15-089.html [Accessed 24 Aug 2021].Suche in Google Scholar

13. Martin, JA, Hamilton, BE, Osterman, MJK, Driscoll, AK, Drake, P. Births: final data for 2017. Natl Vital Stat Rep 2018;67:1–50.Suche in Google Scholar

14. National Center for Health Statistics. Birth data files, 2018. Public-use data file and documentation. Available from: https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm. 2019.Suche in Google Scholar

15. Harris, PA, Taylor, R, Thielke, R, Payne, J, Gonzalez, N, Conde, JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf 2009;42:377–81. https://doi.org/10.1016/j.jbi.2008.08.010.Suche in Google Scholar PubMed PubMed Central

16. Elimian, A, Smith, K, Williams, M, Knudtson, E, Goodman, JR, Escobedo, MB. A randomized controlled trial of intramuscular vs. vaginal progesterone for the prevention of recurrent preterm birth. Int J Gynecol Obstet 2016;134:169–72. https://doi.org/10.1016/j.ijgo.2016.01.010.Suche in Google Scholar

17. DeNoble, AE, Wynn, CE, Weaver, KE, Wheeler, SM, Swamy, GK. Factors associated with utilization of 17-hydroxyprogesterone caproate for the prevention of recurrent preterm birth. Am J Perinatol 2019;37:264–70. https://doi.org/10.1055/s-0039-1678532.Suche in Google Scholar

18. Sibai, BM, Istwan, NB, Palmer, B, Stanziano, GJ. Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011. Am J Perinatol 2012;29:635–42. https://doi.org/10.1055/s-0032-1311979.Suche in Google Scholar

19. Hydery, T, Price, MK, Greenwood, BC, Takeshita, M, Kunte, PS, Mauro, RP, et al.. Evaluation of progesterone utilization and birth outcomes in a state medicaid plan. Pharmacotherapy 2017;37:1328–34. https://doi.org/10.1002/phar.2020.Suche in Google Scholar

20. Geller, SE, Koch, A, Pellettieri, B, Carnes, M. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress? J Wom Health 2011;20:315–20. https://doi.org/10.1089/jwh.2010.2469.Suche in Google Scholar

21. Yancey, AK, Ortega, AN, Kumanyika, SK. Effective recruitment and retention of minority research participants. Annu Rev Publ Health 2006;27:1–28. https://doi.org/10.1146/annurev.publhealth.27.021405.102113.Suche in Google Scholar

22. Ness, RB, Nelson, DB, Kumanyika, SK, Grisso, JA. Evaluating minority recruitment into clinical studies: how good are the data? Ann Epidemiol 1997;7:472–8. https://doi.org/10.1016/s1047-2797(97)00080-x.Suche in Google Scholar

23. Burke, J, Brown, D, Lisabeth, L, Sanchez, B, Morgenstern, L. Enrollment of women and minorities in NINDS trials. Neurology 2011;76:354–60. https://doi.org/10.1212/wnl.0b013e3182088260.Suche in Google Scholar

24. Seidler, EM, Keshaviah, A, Brown, C, Wood, E, Granick, L, Kimball, AB. Geographic distribution of clinical trials may lead to inequities in access. Clin Invest 2014;4:373–80. https://doi.org/10.4155/cli.14.21.Suche in Google Scholar

25. Ghidei, L, Murray, A, Singer, J. Race, research, and women’s health: best practice guidelines for investigators. Obstet Gynecol 2019;133:815–8. https://doi.org/10.1097/aog.0000000000003157.Suche in Google Scholar

26. Kaplan, JB, Bennett, T. Use of race and ethnicity in biomedical publication. JAMA 2003;289:2709–16. https://doi.org/10.1001/jama.289.20.2709.Suche in Google Scholar PubMed

Received: 2021-08-24
Accepted: 2022-03-27
Published Online: 2022-08-29
Published in Print: 2022-09-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. Neonatal and child mortality – are they different in developing and developed countries?
  4. WAPM Guideline
  5. First trimester examination of fetal anatomy: clinical practice guideline by the World Association of Perinatal Medicine (WAPM) and the Perinatal Medicine Foundation (PMF)
  6. Original Articles – Obstetrics
  7. Symptoms of maternal psychological distress during pregnancy: sex-specific effects for neonatal morbidity
  8. Efficacy of the lactate dehydrogenase (LDH)/lymphocyte ratio (LLR) to reduce the need for X-ray in pregnant patients with COVID-19
  9. Attitude of pregnant and lactating women toward COVID-19 vaccination in Jordan: a cross-sectional study
  10. Association between maternal thyroid function and risk of gestational hypertension and preeclampsia
  11. Evaluation of umbilical cord immune cells in pregnancies with autoimmune disorders and/or methylenetetrahydrofolate reductase polymorphisms
  12. The association between induction of labour in nulliparous women at term and subsequent spontaneous preterm birth: a retrospective cohort study
  13. Transvaginally surgically treatment of early postpartum hemorrhage caused by lower uterine segment atony
  14. Value of soluble fms-like tyrosine kinase-1/placental growth factor test in third trimester of pregnancy for predicting preeclampsia in asymptomatic women
  15. Fetal growth regulation via insulin-like growth factor axis in normal and diabetic pregnancy
  16. Intrapartum cardiotocography in pregnancies with and without fetal CHD
  17. Racial and ethnic representation in 17-hydroxyprogesterone caproate preterm birth prevention studies: a systematic review
  18. Original Articles – Fetus
  19. Improved method for revising the Israel birthweight references
  20. A single center experience in 90 cases with nonimmune hydrops fetalis: diagnostic categories ‒ mostly aneuploidy and still often idiopathic
  21. Original Articles – Neonates
  22. Diagnosis of congenital infections in premature, low-birthweight newborns with intrauterine growth restriction caused by cytomegalovirus (CMV), herpes simplex virus (HSV), Parvo-B 19, and Zika virus: a systematic review
  23. The impact of COVID-19 on smoking cessation in pregnancy
  24. Letter to the Editor
  25. Early placenta previa percreta and treatment with supracervical abortion hysterectomy
Heruntergeladen am 19.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpm-2021-0425/html
Button zum nach oben scrollen